The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
2018 AHRMM CQO Summit:
Each year at the annual AHRMM Cost, Quality and Outcom
Webcast
Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician con
Webcast
Teresa Dail, chief supply chain officer, VUMC and 2018 AHRMM board chair, shares AHRMM’s definition of clinical integration and why a clinical
Supply Chain Strategies & Solutions Article
Supplier Relationship Management (SRM) redefines business expectations and brings a dynamic and strategic approach to the supply chain.
Toolkits/Methodology
Free professional strengths finder grid template.
Webcast
Nicole Mazzei-Williams, region director, TRIOSE, discusses working at the most optimum level when your individual strengths are used.